| Bioactivity | Acetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research[1]. |
| Target | Growth hormone releasing factor, GRF; Growth hormone, GH |
| Name | Acetyl-(D-Arg2)-GRF (1-29) amide (human) |
| CAS | 93942-91-7 |
| Sequence | Ac-Tyr-{d-Arg}-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Shortening | Ac-Y-{d-Arg}-DAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| Formula | C154H255N47O43S |
| Molar Mass | 3485.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lumpkin MD, et al. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Endocrinology. 1989 Mar;124(3):1522-31. |